Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1061-1070 of 1760 for

Edit search filters
  1. Phase 3 Frontline Therapy Trial In Patients With Advanced Classical Hodgkin Lymphoma

    Rochester, MN

  2. Isotretinoin With or Without Monoclonal Antibody Ch14.18, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma

    Rochester, MN

  3. Patient Self-sampling Of HPV To Screen For Cervical Cancer

    Rochester, MN

  4. A Study Of TAR-200 In Combination With Cetrelimab And Cetrelimab Alone In Participants With Muscle-Invasive Urothelial Carcinoma Of The Bladder

    Jacksonville, FL, Rochester, MN

  5. A Study To Test The Addition Of Nivolumab To Chemotherapy To Treat Soft Tissue Sarcoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. A Study To Evaluate Binimetinib In Combination With Encorafenib In Patients With Pancreatic Malignancies And A Somatic BRAFV600E Mutation

    Scottsdale/Phoenix, AZ, Rochester, MN

  7. Safety And Efficacy Of ALLO-605 An Anti-BCMA Allogeneic CAR T Cell Therapy In Patients With Relapsed/Refractory Multiple Myeloma

    Jacksonville, FL, Rochester, MN

  8. Short Course Radiotherapy For The Treatment Of Patients With Glioblastoma, SAGA Study

    Albert Lea, MN, Scottsdale/Phoenix, AZ, Eau Claire, WI, Jacksonville, FL, La Crosse, WI, Mankato, MN, Rochester, MN

  9. Gemcitabine Plus Cisplatin With Or Without Bintrafusp Alfa (M7824) In Participants With 1L Biliary Tract Cancer (BTC)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. A Study To Evaluate The Safety And Effectiveness Of Lisocatagene Maraleucel In Patients

    Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer